drugset / Trial / NCT00242281

APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat

NCT00242281 ↗

Phase 3 Completed 600 enrolled Advancis Pharmaceutical Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to evaluate the efficacy of APC 111 MP Tablet, 775 mg tablet, given orally (PO)once daily (QD) for 10 days compared to that of Penicillin VK, 250 mg PO four times daily (QID) for 10 days in terms of bacteriological outcome at the Test-of-Cure (TOC) Visit (Day 14-18) in the eligible Per-Protocol bacteriological (PPb) population.

Timeline

Start
2005-11
Primary completion
—
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject APC 111 MP Unknown 775 mg Oral